Category: Medication & Treatments
-
ICER Midwest review

On January 23, 2020 the ICER review board met in a public meeting, along with doctors and patient advocates to determine the efficacy and availability of the newest class of migraine medications. There was much testimony given about the patient trials and results of those. Concurrently, there was testimony given about prescriber limits and cost…
-
New Preventive Treatment

FDA APPROVES FIRST CGRP INHIBITOR FOR PREVENTION OF MIGRAINE ATTACKS “For years the migraine community has been advocating for new treatment options that are specifically designed to treat migraine, a debilitating and often stigmatized disease. Today we celebrate the tireless work of researchers to better understand the biology of migraine and their ability to bring…
